Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy

JACC: Cardiovascular Imaging

Volumn 6, Issue 4, 2013, Pages 475-484

  Puntmann, Valentina O ^a   Voigt, Tobias ^b   Chen, Zhong ^a   Mayr, Manuel ^c   Karim, Rashed ^a   Rhode, Kawal ^a   Pastor, Ana ^a   Carr White, Gerald ^a   Razavi, Reza ^a   Schaeffter, Tobias ^a   Nagel, Eike ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b PHILIPS RESEARCH LABORATORIES   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

diffuse fibrosis; hypertrophic cardiomyopathy; late gadolinium enhancement; T1 mapping

Indexed keywords

GADOBUTROL;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC ACCURACY; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART MUSCLE FIBROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AREA UNDER CURVE; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CONTRAST MEDIA; FEMALE; FIBROSIS; HUMANS; LOGISTIC MODELS; LONDON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84876157733     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2012.08.019     Document Type: Article

References (32)

1. J.A. Hill, E.N. Olson Cardiac plasticity N Engl J Med 358 2008 1370 1380
2. S.W. Van den Borne, J. Diez, W.M. Blankesteijn, J. Verjans, L. Hofstra, J. Narula Myocardial remodeling after infarction: the role of myofibroblasts Nat Rev Cardiol 7 2010 30 37
3. J. Barallobre-Barreiro, A. Didangelos, F.A. Schoendube Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia-reperfusion injury Circulation 125 2012 789 802
4. C.Y. Ho, B. Lopez, O.R. Coelho-Filho Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy N Engl J Med 363 2010 552 563
5. O. Bruder, A. Wagner, C.J. Jensen Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
6. O. Bruder, S. Schneider, D. Nothnagel EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase J Am Coll Cardiol 54 2009 1457 1466
7. W.G. Rehwald, D.S. Fieno, E.L. Chen, R.J. Kim, R.M. Judd Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury Circulation 105 2002 224 229
8. R.J. Kim, E. Wu, A. Rafael The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
9. O. Grebe, I. Paetsch, H.A. Kestler Optimal acquisition parameters for contrast enhanced magnetic resonance imaging after chronic myocardial infarction J Cardiovasc Magn Reson 4 2003 575 587
10. V.O. Puntmann, C. Jahnke, R. Gebker Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy Am J Cardiol 106 2010 1016 1022
11. N. Mewton, C.Y. Liu, P. Croisille, D. Bluemke, J.A. Lima Assessment of myocardial fibrosis with cardiovascular magnetic resonance J Am Coll Cardiol 57 2011 891 903
12. L. Iles, H. Pfluger, A. Phrommintikul Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping J Am Coll Cardiol 52 2008 1574 1580
13. U. Blume, T. Lockie, C. Stehning Interleaved T(1) and T(2) relaxation time mapping for cardiac applications J Magn Reson Imaging 29 2009 480 487
14. D.R. Messroghli, A. Radjenovic, S. Kozerke, D.M. Higgins, M.U. Sivananthan, J.P. Ridgway Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart Magn Reson Med 52 2004 141 146
15. D.R. Messroghli, K. Walters, S. Plein Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction Magn Reson Med 58 2007 34 40
16. S.K. Piechnik, V.M. Ferreira, E. Dall'Armellina Shortened modified Look-Locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold J Cardiovasc Magn Reson 12 2010 69
17. B.J. Maron, W.J. McKenna, G.K. Danielson et al. American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Classification of Cardiomyopathies. European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
18. P. Elliott, B. Andersson, E. Arbustini Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 29 2008 270 276
19. S. Natori, S. Lai, J.P. Finn Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity AJR Am J Roentgenol 186 Suppl 2006 S357 S365
20. C.M. Kramer, J. Barkhausen, S.D. Flamm, R.J. Kim, E. Nagel Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocol Standardized cardiovascular magnetic resonance imaging (CMR) protocols, Society for Cardiovascular Magnetic Resonance: Board of Trustees Task Force on Standardized Protocols J Cardiovasc Magn Reson 10 2008 35
21. C. Buerger, T. Schaeffter, A.P. King Hierarchical adaptive local affine registration for fast and robust respiratory motion estimation Med Image Anal 15 2011 551 564
22. O.T. Karlsen, R. Verhagen, W.M.M. Bovée Parameter estimation from Rician-distributed data sets using a maximum likelihood estimator: Application to t1 and perfusion measurements Magn Reson Med 41 1999 614 623
23. E.B. Schelbert, S.M. Testa, C.G. Meier Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus J Cardiovasc Magn Reson 13 2011 16 30
24. A.S. Flett, M.P. Hayward, M.T. Ashworth Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 2010 138 144
25. M. Ugander, A.J. Oki, L.Y. Hsu Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology Eur Heart J 33 2012 1268 1278
26. A.M. Maceira, J. Joshi, S.K. Prasad Cardiovascular magnetic resonance in cardiac amyloidosis Circulation 111 2005 186 193
27. C. Jellis, J. Wright, D. Kennedy Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy Circ Cardiovasc Imaging 4 2011 693 702
28. R. Martos, J. Baugh, M. Ledwidge Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction Circulation 115 2007 888 895
29. P. Sharma, J. Socolow, S. Patel, R.I. Pettigrew, J.N. Oshinski Effect of Gd-DTPA-BMA on blood and myocardial T1 at 1.5T and 3T in humans J Magn Reson Imaging 23 2006 323 330
30. B.R. Knowles, P.G. Batchelor, V. Parish Pharmacokinetic modeling of delayed gadolinium enhancement in the myocardium Magn Reson Med 60 2008 1524 1530
31. P. Anversa, B. Hiler, R. Ricci, G. Guideri, G. Olivetti Myocyte cell loss and myocyte hypertrophy in the aging rat heart J Am Coll Cardiol 8 1986 1441 1448
32. B. Sievers, W.G. Rehwald, T.S. Albert Respiratory motion and cardiac arrhythmia effects on diagnostic accuracy of myocardial delayed-enhanced MR imaging in canines Radiology 247 2008 106 114